36 
Draft  of  a  Proposed  Drug  Law. 
/Am.  Jour.  Pharm. 
\     January,  1909. 
DRAFT  OF  A  PROPOSED  DRUG  LAW  FOR  THE  STATE 
OF  PENNSYLVANIA. 
An  Act. 
To  prevent  the  manufacture  and  sale  of  adulterated  or  misbranded 
drugs,  denning  the  word  "  drug,"  prescribing  penalties  for  vio- 
lation of  this  Act  and  the  means  and  method  of  its  enforcement. 
Section  i. — Be  it  enacted  by  the  Senate  and  House  of  Represen- 
tatives of  the  Commonwealth  of  Pennsylvania  in  General  Assembly 
met,  and  it  is  hereby  enacted  by  the  authority  of  the  same  That  it 
shall  be  unlawful  for  any  person,  partnership  or  corporation  to 
manufacture  or  sell,  offer  for  sale,  or  have  in  possession  with  intent 
to  sell,  any  drug  which  is  adulterated  or  misbranded  within  the 
meaning  of  this  Act. 
Section  2. — That  the  term  drug  as  used  in  this  Act  shall  include 
all  medicines  and  preparations  recognized  in  the  United  States  Phar- 
macopoeia, the  National  Formulary  or  the  American  Homoeopathic 
Pharmacopoeia  for  the  internal  or  external  use,  and  any  substance 
or  mixture  of  substances  intended  to  be  used  for  the  cure,  mitiga- 
tion or  prevention  of  disease  of  either  man  or  other  animals. 
Section  3. — That  for  the  purpose  of  this  Act  an  article  shall  be 
deemed  to  be  adulterated: 
First. — If  a  drug  is  sold  under  or  by  any  name  recognized  by  the 
United  States  Pharmacopoeia,  the  National  Formulary  or  the  Amer- 
ican Homoeopathic  Pharmacopoeia  it  differs  from  the  standard  of 
strength,  quality  or  purity  as  determined  by  the  test  or  formula  laid 
down  in  the  United  States  Pharmacopoeia,  the  National  Formulary 
or  the  American  Homoeopathic  Pharmacopoeia.  Provided  that  no 
drug  defined  in  the  United  States  Pharmacopoeia,  the  National 
Formulary  or  the  American  Homoeopathic  Pharmacopoeia  shall  be 
deemed  to  be  adulterated  under  this  provision  if  the  standard  of 
strength,  quality  or  purity  be  plainly  stated  upon  the  bottle,  box  or 
other  container  thereof,  although  the  standard  may  differ  from  that 
determined  by  the  test  or  formula  laid  down  by  the  United  States 
Pharmacopoeia,  the  National  Formulary  or  the  American  Homoeo- 
pathic Pharmacopoeia. 
Second. — If  its  strength  or  purity  fall  below  the  professed  stand- 
ard or  quality  under  which  it  is  sold. 
